Evaxion Biotech A/S Overview

Evaxion Biotech A/S EBIT

EBIT (Earnings Before Interest and Taxes) analysis for EVAX.

Quarterly EBIT

-$3.83M

↓ 178.77% YoY

As of Mar 31, 2026

Annual EBIT (TTM)

-$11.72M

↑ 11.85% YoY

Trailing 12 months ending Mar 31, 2026

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin